← The Wire
NVAXNasdaq
NOVAVAX INC
Biological Products, (No Diagnostic Substances) · DE · CIK 1000694
Novavax develops vaccines and adjuvants to address global health challenges
$1.46B
Market cap
$9.36
Last close
+5.4%
1D
+4.0%
5D
4.0M
Volume
Price · last 39 sessions+16.6%
May 4L $8.03 · H $11.09Jun 29
344
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
8-K/AShareholder VoteNov 2, 20238-K/AExecutive ChangeDec 9, 20228-K/AExecutive ChangeDec 16, 20208-K/AAcquisition / DispositionAug 10, 20208-K/AAuditor ChangeMay 7, 20148-K/AAuditor ChangeMay 2, 2014
In the News
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance